UPCC 11922 A Randomized Trial Of The Effect Of Encouraging Medical Cannabis As A Component Of Outpatient Palliative Care In Patients With Cancer

Study on Medical Cannabis Use in Palliative Care for Cancer Patients

Enrolling By Invitation
18 years or above
All
Phase N/A
208 participants needed
1 Location

Brief description of study

This randomized controlled trial will assess the effects on quality of life of two approaches to symptom management among new patients referred to a palliative care oncology clinic.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Cancer
  • Age: 18 years or above
  • Gender: All

Inclusion Criteria:

  • Be a new patient at an outpatient palliative care clinic
  • Resident of Pennsylvania
  • Over 18 years of age

Exclusion Criteria:

  • Prior use of certain symptom focused therapies
  • Currently pregnant

This study investigates the use of medical cannabis as part of outpatient palliative care for patients with cancer. The purpose of this study is to assess how different approaches to symptom management can affect the quality of life in cancer patients who are new to palliative care.

Participants will be randomly assigned to different study arms to compare the effects of medical cannabis on symptom management. The study will involve regular assessments to understand how medical cannabis impacts the participants' quality of life.

  • Who can participate: Participants must be new patients at an outpatient palliative care clinic, residents of Pennsylvania, and over 18 years of age. Those who have used certain symptom-focused therapies or are currently pregnant are not eligible.
  • Study details: Participants will be randomly assigned to receive investigational medical cannabis as part of their symptom management plan. They will be monitored to evaluate the impact on their quality of life.
Updated on 16 Jul 2026. Study ID: 22-0216
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator